GSK's Growth Gamble: Walmsley's Steady Hand Faces Test
Five years into her tenure, CEO Emma Walmsley has stabilised GSK's ship, but looming patent cliffs and vaccine market pressures cast shadows over ambitious growth targets.
Five years into her tenure, CEO Emma Walmsley has stabilised GSK's ship, but looming patent cliffs and vaccine market pressures cast shadows over ambitious growth targets.